Your browser doesn't support javascript.
loading
IG-MYC + neoplasms with precursor B-cell phenotype are molecularly distinct from Burkitt lymphomas.
Wagener, Rabea; López, Cristina; Kleinheinz, Kortine; Bausinger, Julia; Aukema, Sietse M; Nagel, Inga; Toprak, Umut H; Seufert, Julian; Altmüller, Janine; Thiele, Holger; Schneider, Christof; Kolarova, Julia; Park, Jeongbin; Hübschmann, Daniel; Murga Penas, Eva M; Drexler, Hans G; Attarbaschi, Andishe; Hovland, Randi; Kjeldsen, Eigil; Kneba, Michael; Kontny, Udo; de Leval, Laurence; Nürnberg, Peter; Oschlies, Ilske; Oscier, David; Schlegelberger, Brigitte; Stilgenbauer, Stephan; Wössmann, Wilhelm; Schlesner, Matthias; Burkhardt, Birgit; Klapper, Wolfram; Jaffe, Elaine S; Küppers, Ralf; Siebert, Reiner.
Affiliation
  • Wagener R; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
  • López C; Institute of Human Genetics, Christian-Albrechts University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Kleinheinz K; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
  • Bausinger J; Institute of Human Genetics, Christian-Albrechts University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Aukema SM; Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Nagel I; Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg, Germany.
  • Toprak UH; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
  • Seufert J; Institute of Human Genetics, Christian-Albrechts University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Altmüller J; Institute of Human Genetics, Christian-Albrechts University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Thiele H; Institute of Pharmacology, Christian-Albrechts University, Kiel, Germany.
  • Schneider C; Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Kolarova J; Bioinformatics and Omics Data Analytics, DKFZ, Heidelberg, Germany.
  • Park J; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Hübschmann D; Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Murga Penas EM; Bioinformatics and Omics Data Analytics, DKFZ, Heidelberg, Germany.
  • Drexler HG; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Attarbaschi A; Cologne Center for Genomics, Center for Molecular Medicine Cologne (CMMC), University of Cologne, Cologne, Germany.
  • Hovland R; Cologne Center for Genomics, University of Cologne, Cologne, Germany.
  • Kjeldsen E; Department of Internal Medicine III, University of Ulm, Ulm, Germany.
  • Kneba M; Institute of Human Genetics, Ulm University and Ulm University Medical Center, Ulm, Germany.
  • Kontny U; Institute of Human Genetics, Christian-Albrechts University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • de Leval L; Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Nürnberg P; Faculty of Biosciences, Heidelberg University, Heidelberg, Germany.
  • Oschlies I; Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Oscier D; Institute of Pharmacy and Molecular Biotechnology and Bioquant, University of Heidelberg, Heidelberg, Germany.
  • Schlegelberger B; Pediatric Immunology, Hematology and Oncology, University Hospital Heidelberg, Heidelberg, Germany.
  • Stilgenbauer S; Institute of Human Genetics, Christian-Albrechts University Kiel & University Hospital Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Wössmann W; German Collection of Microorganisms and Cell Cultures, Leibniz Institute, Braunschweig, Germany.
  • Schlesner M; Department of Pediatric Hematology and Oncology, St Anna Children's Hospital, Medical University of Vienna, Vienna, Austria.
  • Burkhardt B; Department for Medical Genetics, Haukeland University Hospital, Bergen, Norway.
  • Klapper W; Cancer Cytogenetics Section, Hemodiagnostic Laboratory, Department of Haematology, Cancer and Inflammation Center, Aarhus University Hospital, Aarhus, Denmark.
  • Jaffe ES; Department of Hematology, University Hospital Schleswig-Holstein, Kiel, Germany.
  • Küppers R; Division of Pediatric Hematology, Oncology and Stem Cell Transplantation, Medical Faculty, RWTH Aachen University, Aachen, Germany.
  • Siebert R; Institute of Pathology, Lausanne University Hospital, Lausanne, Switzerland.
Blood ; 132(21): 2280-2285, 2018 11 22.
Article in En | MEDLINE | ID: mdl-30282799
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins c-myc / Burkitt Lymphoma / Precursor Cells, B-Lymphoid / Precursor Cell Lymphoblastic Leukemia-Lymphoma / V(D)J Recombination Type of study: Diagnostic_studies / Observational_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2018 Type: Article Affiliation country: Germany
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Proto-Oncogene Proteins c-myc / Burkitt Lymphoma / Precursor Cells, B-Lymphoid / Precursor Cell Lymphoblastic Leukemia-Lymphoma / V(D)J Recombination Type of study: Diagnostic_studies / Observational_studies Limits: Adolescent / Adult / Aged / Child / Child, preschool / Female / Humans / Male / Middle aged Language: En Journal: Blood Year: 2018 Type: Article Affiliation country: Germany